Interaction of heparin and heparin-derived oligosaccharides with synthetic peptide analogues of the heparin-binding domain of heparin/heparan sulfate-interacting protein.
BACKGROUND
Although protamine is effective as an antidote of heparin, there is a need to replace protamine due to its side effects. HIP peptide has been reported to neutralize the anticoagulant activity of heparin. The interaction of HIP analog peptides with heparin and heparin-derived oligosaccharides is investigated in this paper.


METHODS
Seven analogues of the heparin-binding domain of heparin/heparan sulfate-interacting protein (HIP) were synthesized, and their interaction with heparin was characterized by heparin affinity chromatography, isothermal titration calorimetry, and NMR.


RESULTS
NMR results indicate the imidazolium groups of the His side chains of histidine-containing Hip analog peptide interact site-specifically with heparin at pH 5.5. Heparin has identical affinities for HIP analog peptides of opposite chirality. Analysis by counterion condensation theory indicates the peptide AC-SRPKAKAKAKAKDQTK-NH2 makes on average approximately 3 ionic interactions with heparin that result in displacement of approximately 2 Na+ ions, and ionic interactions account for approximately 46% of the binding free energy at a Na+ concentration of 0.15 M.


CONCLUSIONS
The affinity of heparin for the peptides is strongly dependent on the nature of the cationic side chains and pH. The thermodynamic parameters measured for the interaction of HIP peptide analogs with heparin are strongly dependent on the peptide sequence and pH.


CONCLUSIONS
The information obtained in this research will be of use in the design of new agents for neutralization of the anticoagulant activity of heparin. The site-specific binding of protonated histidine side chains to heparin provides a molecular-level explanation for the pH-dependent binding of beta-amyloid peptides by heparin and heparan sulfate proteoglycan and may have implications for amyloid formation.
Wang
Jing
J
Department of Chemistry, University of California, Riverside, CA 92521, USA.
Rabenstein
Dallas L
DL
D000595:Amino Acid Sequence; D000682:Amyloid / Q000378:metabolism; D000818:Animals; D002846:Chromatography, Affinity; D006493:Heparin / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism*; D008954:Models, Biological; D019906:Nuclear Magnetic Resonance, Biomolecular; D009844:Oligosaccharides / Q000737:chemistry / Q000378:metabolism*; D010455:Peptides / Q000032:analysis / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism*; D011485:Protein Binding; D054730:Protein Interaction Domains and Motifs / Q000502:physiology; D012269:Ribosomal Proteins / Q000737:chemistry* / Q000378:metabolism*; D013552:Swine; D013816:Thermodynamics
D000682:Amyloid; D009844:Oligosaccharides; D010455:Peptides; D012269:Ribosomal Proteins; C035078:ribosomal protein L29; D006493:Heparin